Echelon Wealth Partners Thinks Trulieve Cannabis’ Stock is Going to Recover
April 01 2022 - 12:29PM
TipRanks
In a report released yesterday, Andrew Semple from Echelon Wealth
Partners reiterated a Buy rating on Trulieve Cannabis (TCNNF –
Research Report), with a price target of C$55.00. The company's
shares closed last Friday at $20.81, close to its 52-week low of
$16.99. According to TipRanks.com, Semple is a 4-star analyst with
an average return of 19.5% and a 31.7% success rate. Semple covers
the Basic Materials sector, focusing on stocks such as Ascend
Wellness Holdings LLC, Green Thumb Industries, and Verano Holdings.
The word on The Street in general, suggests a Strong Buy analyst
consensus rating for Trulieve Cannabis with a $56.27 average price
target, a 161.
https://www.tipranks.com/news/blurbs/echelon-wealth-partners-thinks-trulieve-cannabis-stock-is-going-to-recover?utm_source=advfn.com&utm_medium=referral
Trulieve Cannabis (QX) (USOTC:TCNNF)
Historical Stock Chart
From Feb 2023 to Mar 2023
Trulieve Cannabis (QX) (USOTC:TCNNF)
Historical Stock Chart
From Mar 2022 to Mar 2023
